CARGO Therapeutics to Participate in Upcoming Investor Conferences
CARGO Therapeutics (NASDAQ: CRGX), a clinical-stage biotechnology company focused on developing next-generation cell therapies for cancer patients, has announced its participation in two upcoming investor conferences. Gina Chapman, President and CEO, will participate in fireside chats at the Jefferies London Healthcare Conference on November 20 at 11:00 a.m. GMT, and at the Piper Sandler 36th Annual Healthcare Conference on December 4 at 10:30 a.m. EST. Live webcasts will be available in the Investors section of CARGO's website, with replays accessible for approximately 90 days after the presentations.
CARGO Therapeutics (NASDAQ: CRGX), un'azienda biotecnologica in fase clinica focalizzata sullo sviluppo di terapie cellulari di nuova generazione per pazienti oncologici, ha annunciato la sua partecipazione a due prossime conferenze per investitori. Gina Chapman, Presidente e CEO, parteciperà a discussioni informali durante il Jefferies London Healthcare Conference il 20 novembre alle 11:00 GMT e al Piper Sandler 36th Annual Healthcare Conference il 4 dicembre alle 10:30 EST. Saranno disponibili webcast dal vivo nella sezione Investitori del sito web di CARGO, con registrazioni accessibili per circa 90 giorni dopo le presentazioni.
CARGO Therapeutics (NASDAQ: CRGX), una empresa biotecnológica en etapas clínicas centrada en desarrollar terapias celulares de próxima generación para pacientes con cáncer, ha anunciado su participación en dos próximas conferencias para inversores. Gina Chapman, presidenta y directora ejecutiva, participará en charlas informales en la Jefferies London Healthcare Conference el 20 de noviembre a las 11:00 a.m. GMT, y en la Piper Sandler 36th Annual Healthcare Conference el 4 de diciembre a las 10:30 a.m. EST. Se ofrecerán transmisiones en vivo en la sección de Inversores del sitio web de CARGO, con repeticiones accesibles durante aproximadamente 90 días después de las presentaciones.
CARGO Therapeutics (NASDAQ: CRGX), 암 환자를 위한 차세대 세포 치료제 개발에 중점을 둔 임상 단계의 생명공학 회사가 다가오는 두 개의 투자자 회의에 참여할 것이라고 발표했습니다. 지나 채프먼, 회장 겸 CEO는 11월 20일 오전 11시 GMT에 제퍼리스 런던 헬스케어 컨퍼런스와 12월 4일 오전 10시 30분 EST에 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에서 대화에 참여할 예정입니다. CARGO 웹사이트의 투자자 섹션에서 생중계 웹캐스트가 제공되며, 프레젠테이션 후 약 90일 동안 다시 볼 수 있습니다.
CARGO Therapeutics (NASDAQ: CRGX), une entreprise de biotechnologie en phase clinique axée sur le développement de thérapies cellulaires de nouvelle génération pour les patients atteints de cancer, a annoncé sa participation à deux prochaines conférences pour investisseurs. Gina Chapman, présidente et PDG, participera à des discussions informelles lors de la Conférence de Santé de Jefferies à Londres le 20 novembre à 11h00 GMT, et lors de la 36e Conférence Annuelle de Santé de Piper Sandler le 4 décembre à 10h30 EST. Des webcasts en direct seront disponibles dans la section Investisseurs du site web de CARGO, avec des rediffusions accessibles pendant environ 90 jours après les présentations.
CARGO Therapeutics (NASDAQ: CRGX), ein biotechnologisches Unternehmen in klinischen Phasen, das sich auf die Entwicklung von Zelltherapien der nächsten Generation für Krebspatienten konzentriert, hat seine Teilnahme an zwei bevorstehenden Investorenkonferenzen angekündigt. Gina Chapman, Präsidentin und CEO, wird an informellen Gesprächen auf der Jefferies London Healthcare Conference am 20. November um 11:00 Uhr GMT und auf der Piper Sandler 36th Annual Healthcare Conference am 4. Dezember um 10:30 Uhr EST teilnehmen. Live-Webcasts werden im Investorenbereich der CARGO-Website verfügbar sein, mit Wiederholungen, die etwa 90 Tage nach den Präsentationen zugänglich sind.
- None.
- None.
SAN CARLOS, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- CARGO Therapeutics, Inc. (NASDAQ: CRGX), a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients, today announced that the company will be participating in the following investor conferences.
Jefferies London Healthcare Conference
Gina Chapman, President and Chief Executive Officer, is scheduled to participate in a fireside chat on Wednesday, November 20, at 11:00 a.m. GMT / 3:00 a.m. PST, in London, UK.
Piper Sandler 36th Annual Healthcare Conference
Gina Chapman, President and Chief Executive Officer, is scheduled to participate in a fireside chat on Wednesday, December 4, at 10:30 a.m. EST / 7:30 a.m. PST, in New York City, NY.
Interested parties can access the live webcasts for the conferences in the Investors section of CARGO’s website under News & Events. The webcast replays will be available after the conclusion of the live presentations for approximately 90 days.
About CARGO Therapeutics
CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next-generation, potentially curative cell therapies for cancer patients. CARGO’s programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns and unreliable supply. CARGO is currently evaluating firicabtagene autoleucel (firi-cel), an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, in a potentially pivotal Phase 2 clinical study in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy. CARGO has developed proprietary cell engineering platform technologies which it leverages to develop a pipeline of programs that incorporate multiple transgene therapeutic “cargo” designed to enhance CAR T-cell persistence. This includes the CRG-023 program, which incorporates a novel tri-specific CAR T with CD2 co-stimulation that is designed to provide more patients with a broad range of B-cell malignancies with durable responses by addressing several known causes of relapse, resulting in a potential best-in-class CAR T-cell therapy. CARGO’s leadership and team have significant experience in developing, engineering, manufacturing, and commercializing oncology and cell therapy products. For more information, please visit the CARGO Therapeutics website at https://cargo-tx.com/.
Follow us on LinkedIn: CARGO Therapeutics
Follow us on X (Twitter): @CARGOTx
Contacts
Media Contact:
Kimberly Muscara
kimberly@redhousecomms.com
Investor Contact:
Jessica Serra
jserra@cargo-tx.com
Laurence Watts
laurence@newstreetir.com
FAQ
When is CARGO Therapeutics (CRGX) presenting at the Jefferies London Healthcare Conference?
When is CARGO Therapeutics (CRGX) presenting at the Piper Sandler Healthcare Conference?
How long will CARGO Therapeutics (CRGX) conference webcasts be available for replay?
Where can I watch CARGO Therapeutics (CRGX) investor conference presentations?
